UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

Suicidality among users of glucagon‐like peptide‐1 receptor agonists: An emerging signal?

Diabetes, obesity & metabolism, 2024-04, Vol.26 (4), p.1150-1156

2024

Link zum Volltext

Verfügbarkeit prüfen

Active‐comparator restricted disproportionality analysis for pharmacovigilance signal detection studies of chronic disease medications: An example using sodium/glucose cotransporter 2 inhibitors

British journal of clinical pharmacology, 2023-02, Vol.89 (2), p.431-439

2023

Link zum Volltext

Verfügbarkeit prüfen

Sodium/Glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis: An Example of Complementary Evidence for Rare Adverse Events

American journal of epidemiology, 2021-08, Vol.190 (8), p.1572-1581

2021

Link zum Volltext

Verfügbarkeit prüfen

Post-initiation predictors of discontinuation of the sodium-glucose cotransporter-2 inhibitors: A comparative cohort study from the United Kingdom

Diabetes, obesity & metabolism, 2023-12, Vol.25 (12), p.3490-3500

2023

Link zum Volltext

Verfügbarkeit prüfen

Insulin, hypoglycaemia and dementia: A causal mediation analysis showcasing challenges and potential opportunities

Diabetes, obesity & metabolism, 2024-03, Vol.26 (3), p.1120-1124

2024

Link zum Volltext

Verfügbarkeit prüfen

Capsule Commentary on Franklin et al., Time to Filling of New Prescriptions for Chronic Disease Medications Among a Cohort of Elderly Patients in the USA

Journal of general internal medicine : JGIM, 2018-11, Vol.33 (11), p.1955-1955

Gamble, John-Michael

2018

Link zum Volltext

Verfügbarkeit prüfen

Adverse events associated with sodium glucose co-transporter 2 inhibitors: an overview of quantitative systematic reviews

Therapeutic Advances in Drug Safety, 2021-01, Vol.12, p.2042098621989134-2042098621989134

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis

BMJ open, 2019-01, Vol.9 (1), p.e022577

2019

Link zum Volltext

Verfügbarkeit prüfen

Profile of Ipragliflozin, an Oral SGLT-2 Inhibitor for the Treatment of Type 2 Diabetes: The Evidence to Date

Drug design, development and therapy, 2021-01, Vol.15, p.3057-3069

2021

Link zum Volltext

Verfügbarkeit prüfen

Perceptions of Health Care Providers Regarding a Mobile Health Intervention to Manage Chronic Obstructive Pulmonary Disease: Qualitative Study

JMIR mHealth and uHealth, 2019-06, Vol.7 (6), p.e13950-e13950

2019

Link zum Volltext

Verfügbarkeit prüfen

Five comparative cohorts to assess the risk of genital tract infections associated with sodium‐glucose cotransporter‐2 inhibitors initiation in type 2 diabetes mellitus

Diabetic medicine, 2022-08, Vol.39 (8), p.e14858-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Diabetes and the occurrence of infection in primary care: a matched cohort study

BMC infectious diseases, 2018-02, Vol.18 (1), p.67-67, Article 67

2018

Link zum Volltext

Verfügbarkeit prüfen

Prescribing Trends of the Sodium–Glucose Cotransporter-2 Inhibitors Among Different Physician Specialties in Canada (2015–2021)

Canadian journal of diabetes, 2023-03, Vol.47 (2), p.153-161

2023

Link zum Volltext

Verfügbarkeit prüfen

Thiazide Diuretic–Induced Change in Fasting Plasma Glucose: a Meta-analysis of Randomized Clinical Trials

Journal of general internal medicine : JGIM, 2020-06, Vol.35 (6), p.1849-1860

2020

Link zum Volltext

Verfügbarkeit prüfen

Too young for Cannabis? Choice of minimum legal age for legalized non-medical Cannabis in Canada

BMC public health, 2020-05, Vol.20 (1), p.557-557, Article 557

2020

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy of Incretin-Based Therapies in Patients With Type 2 Diabetes Mellitus and CKD: A Systematic Review and Meta-analysis

American journal of kidney diseases, 2016-11, Vol.68 (5), p.733-742

2016

Link zum Volltext

Verfügbarkeit prüfen

The association of sodium‐glucose cotransporter 2 inhibitors with cancer: An overview of quantitative systematic reviews

Endocrinology, diabetes & metabolism, 2020-07, Vol.3 (3), p.e00145-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

The risk of fragility fractures in new users of dipeptidyl peptidase-4 inhibitors compared to sulfonylureas and other anti-diabetic drugs: A cohort study

Diabetes research and clinical practice, 2018-02, Vol.136, p.159-167

2018

Link zum Volltext

Verfügbarkeit prüfen

Features of a mobile health intervention to manage chronic obstructive pulmonary disease: a qualitative study

Therapeutic advances in respiratory disease, 2020, Vol.14, p.175346662095104-1753466620951044

2020

Link zum Volltext

Verfügbarkeit prüfen

The association between diabetes mellitus and incident infections: a systematic review and meta-analysis of observational studies

BMJ open diabetes research & care, 2017-05, Vol.5 (1), p.e000336-e000336

2017

Link zum Volltext

Verfügbarkeit prüfen

Association of insulin dosage with mortality or major adverse cardiovascular events: a retrospective cohort study

The lancet. Diabetes & endocrinology, 2017, Vol.5 (1), p.43-52

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes

Scientific reports, 2018-10, Vol.8 (1), p.15142-10, Article 15142

2018

Link zum Volltext

Verfügbarkeit prüfen

Author’s Reply to Kuss and Rathmann’s Comment on: “Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data”

Drug safety, 2023-05, Vol.46 (5), p.513-514

2023

Link zum Volltext

Verfügbarkeit prüfen

Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections: A Propensity Score–matched Population-based Cohort Study

Canadian journal of diabetes, 2022-06, Vol.46 (4), p.392-403.e13

2022

Link zum Volltext

Verfügbarkeit prüfen

Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK Clinical Practice Research Datalink

BMJ open, 2018-10, Vol.8 (10), p.e023830-e023830

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(89)

Publikationsform

Artikel
(91)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(67)
Life Sciences & Biomedicine
(66)
Humans
(44)
Diabetes
(24)
Endocrinology & Metabolism
(22)
Male
(18)
Female
(17)
Aged
(15)
Diabetes Mellitus, Type 2 - Drug Therapy
(15)
Glucose
(15)
Cohort Studies
(14)
Middle Aged
(14)
Mortality
(14)
General & Internal Medicine
(13)
Health Care Sciences & Services
(12)
Medicine, General & Internal
(12)
Pharmacology & Pharmacy
(12)
Drug Therapy
(11)
Internal Medicine
(11)
Patients
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Suicidality among users of glucagon‐like peptide‐1 receptor agonists: An emerging signal?

Active‐comparator restricted disproportionality analysis for pharmacovigilance signal detection studies of chronic disease medications: An example using sodium/glucose cotransporter 2 inhibitors

Sodium/Glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis: An Example of Complementary Evidence for Rare Adverse Events

Post-initiation predictors of discontinuation of the sodium-glucose cotransporter-2 inhibitors: A comparative cohort study from the United Kingdom

Insulin, hypoglycaemia and dementia: A causal mediation analysis showcasing challenges and potential opportunities

Capsule Commentary on Franklin et al., Time to Filling of New Prescriptions for Chronic Disease Medications Among a Cohort of Elderly Patients in the USA

Adverse events associated with sodium glucose co-transporter 2 inhibitors: an overview of quantitative systematic reviews

Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis

Profile of Ipragliflozin, an Oral SGLT-2 Inhibitor for the Treatment of Type 2 Diabetes: The Evidence to Date

Perceptions of Health Care Providers Regarding a Mobile Health Intervention to Manage Chronic Obstructive Pulmonary Disease: Qualitative Study

Five comparative cohorts to assess the risk of genital tract infections associated with sodium‐glucose cotransporter‐2 inhibitors initiation in type 2 diabetes mellitus

Diabetes and the occurrence of infection in primary care: a matched cohort study

Prescribing Trends of the Sodium–Glucose Cotransporter-2 Inhibitors Among Different Physician Specialties in Canada (2015–2021)

Thiazide Diuretic–Induced Change in Fasting Plasma Glucose: a Meta-analysis of Randomized Clinical Trials

Too young for Cannabis? Choice of minimum legal age for legalized non-medical Cannabis in Canada

Safety and Efficacy of Incretin-Based Therapies in Patients With Type 2 Diabetes Mellitus and CKD: A Systematic Review and Meta-analysis

The association of sodium‐glucose cotransporter 2 inhibitors with cancer: An overview of quantitative systematic reviews

The risk of fragility fractures in new users of dipeptidyl peptidase-4 inhibitors compared to sulfonylureas and other anti-diabetic drugs: A cohort study

Features of a mobile health intervention to manage chronic obstructive pulmonary disease: a qualitative study

The association between diabetes mellitus and incident infections: a systematic review and meta-analysis of observational studies

Association of insulin dosage with mortality or major adverse cardiovascular events: a retrospective cohort study

Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes

Author’s Reply to Kuss and Rathmann’s Comment on: “Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data”

Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections: A Propensity Score–matched Population-based Cohort Study

Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK Clinical Practice Research Datalink

Suchergebnisse filtern